EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis

Journal of Nutritional Biochemistry

Volumn 22, Issue 9, 2011, Pages 886-894

  Yang, Ting Hua ^a,b   Young, Yi Ho ^b   Liu, Shing Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cell death; Cochlear culture; EGb 761; Hearing; Ototoxicity

Indexed keywords

BILOBALIDE; GENTAMICIN; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B; KAEMPFEROL; NITRIC OXIDE; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN STEM RESPONSE; CELL PROTECTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; GUINEA PIG; HAIR CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OTOTOXICITY; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; CELLS, CULTURED; COCHLEA; GENTAMICINS; GINKGO BILOBA; GUINEA PIGS; HAIR CELLS, AUDITORY; MALE; NITRIC OXIDE; PLANT EXTRACTS; RATS; REACTIVE OXYGEN SPECIES;

ANIMALIA; CAVIA; GINKGO BILOBA;

EID: 80051468808     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.009     Document Type: Article

References (52)

1. Heinrich U.R., Helling K., Sifferath M., Brieger J., Li H., Schmidtmann I., et al. Gentamicin increases nitric oxide production and induces hearing loss in guinea pigs. Laryngoscope 2008, 118:1438-1442.
2. López-González M.A., Lucas M., Delgado F., Diaz P. The production of free oxygen radicals and nitric oxide in the rat cochlea. Neurochem Int 1998, 33:55-59.
3. Rizzi M.D., Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 2007, 15:352-357.
4. Sha S.H. Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res 1999, 128:112-118.
5. Takumida M., Popa R., Anniko M. Free radicals in the guinea pig inner ear following gentamicin exposure. ORL J Otorhinolaryngol Relat Spec 1999, 61:63-70.
6. Wu W.J., Sha S.H., Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 2002, 7:171-174.
7. Takumida M., Anniko M. Nitric oxide in guinea pig vestibular sensory cells following gentamicin exposure in vitro. Acta Otolaryngol 2001, 121:346-350.
8. Fetoni A.R., Sergi B., Ferraresi A., Paludetti G., Troiani D. alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study. Int J Audiol 2004, 43:166-171.
9. Jung H.W., Chang S.O., Kim C.S., Rhee C.S., Lim D.H. Effects of Ginkgo biloba extract on the cochlear damage induced by local gentamicin installation in guinea pigs. J Korean Med Sci 1998, 13:525-528.
10. McFadden S.L., Ding D., Salvemini D., Salvi R.J. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Toxicol Appl Pharmacol 2003, 186:46-54.
11. Sha S.H., Schacht J. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: d-methionine is a potential protectant. Hear Res 2000, 142:34-37.
12. Wang A.M., Sha S.H., Lesniak W., Schacht J. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 2003, 47:1836-1841.
13. Bodmer D., Brors D., Pak K., Gloddek B., Ryan A. Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho/Rac/Cdc42. Hear Res 2002, 172:81-86.
14. Corbacella E., Lanzoni I., Ding D., Previati M., Salvi R. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear Res 2004, 197:11-18.
15. Wang J., Van De Water T.R., Bonny C., de Ribaupierre F., Puel J.L., Zine A. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci 2003, 23:8596-8607.
16. Wei X., Zhao L., Liu J., Dodel R.C., Farlow M.R., Du Y. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 2005, 131:513-521.
17. Ylikoski J., Xing-Qun L., Virkkala J., Pirvola U. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res 2002, 166:33-34.
18. Burschka M.A., Hassan H.A., Reineke T., van Bebber L., Caird D.M., Mösges R. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol 2001, 258:213-219.
19. Didier A., Droy-Lefaix M.T., Aurousseau C., Cazals Y. Effects of Ginkgo biloba extract (EGb 761) on cochlear vasculature in the guinea pig: morphometric measurements and laser Doppler flowmetry. Eur Arch Otorhinolaryngol 1996, 253:25-30.
20. Krieglstein J., Beck T., Seibert A. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 1986, 39:2327-2334.
21. Smith P.F., Zheng Y., Darlington C.L. Ginkgo biloba extracts for tinnitus: more hype than hope?. J Ethnopharmacol 2005, 100:95-99.
22. Oberpichler H., Beck T., Abdel-Rahman M.M., Bielenberg G.W., Krieglstein J. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun 1988, 20:349-368.
23. Zhang J., Fu S., Liu S., Mao T., Xiu R. The therapeutic effect of Ginkgo biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. Clin Hemorheol Microcirc 2000, 23:133-138.
24. Yao Z.X., Han Z., Drieu K., Papadopoulos V. Ginkgo biloba extract (EGb 761) inhibits β-amyloid production by lowering free cholesterol levels. J Nutr Biochem 2004, 15:749-756.
25. Kobuchi H., Droy-Lefaix M.T., Christen Y., Packer L. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997, 53:897-903.
26. Marcocci L., Maguire J.J., Droy-Lefaix M.T., Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 1994, 201:748-755.
27. Cheung F., Siow Y.L., Chen W.Z., O K. Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cell. Biochem Pharmacol 1999, 58:1665-1673.
28. Punkt K., Zaitsev S., Park J.K., Wellner M., Buchwalow I.B. Nitric oxide synthase isoforms I, III and protein kinase-Ctheta in skeletal muscle fibres of normal and streptozotocin-induced diabetic rats with and without Ginkgo biloba extract treatment. Histochem J 2001, 33:213-219.
29. Shen J., Wang J., Zhao B., Hou J., Gao T., Xin W. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim Biophys Acta 1998, 1406:228-236.
30. Kaptan Z.K., Emir H., Gocmen H., Uzunkulaoglu H., Karakas A., Senes M., et al. Ginkgo biloba, a free oxygen radical scavenger, affects inflammatory mediators to diminish the occurrence of experimental myringosclerosis. Acta Otolaryngol 2008, 17:1-6.
31. Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richards J.A., et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 2000, 81:668-678.
32. Gryglewski R.J., Korbut R., Robak J., Sweiss J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 1987, 36:317-322.
33. Kudolo G.E., Dorsey S., Blodgett J. Effect of ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and type 2 diabetic subjects. Thromb Res 2003, 108:151-160.
34. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988, 37:837-841.
35. Maitra I., Marcocci L., Droy-Lefaix M.T., Packer L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 1995, 49:1649-1655.
36. Oyama Y., Chikahisa L., Ueha T., Kanemaru K., Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996, 712:349-352.
37. Van de Water T., Ruben R.J. Growth of the inner ear in organ culture. Ann Otol Rhinol Laryngol 1974, 83:1-16.
38. Sobkowicz H.M., Loftus J.M., Slapnick S.M. Tissue culture of the organ of Corti. Acta Otolaryngol Suppl 1993, 502:3-36.
39. Salt A.N., Gill R.M., Plontke S.K. Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope 2008, 118:1793-1800.
40. Day A.S., Lue J.H., Yang T.H., Young Y.H. Effect of intratympanic application of aminoglycosides on click-evoked myogenic potentials in guinea pigs. Ear Hear 2007, 28:18-25.
41. Trayner I.D., Rayner A.P., Freeman G.E., Farzaneh F. Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine 123 (H2R123). J Immunol Methods 1995, 186:275-284.
42. Sha S.H., Taylor R., Forge A., Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001, 155:1-8.
43. Guthrie O.W. Aminoglycoside induced ototoxicity. Toxicology 2008, 249:91-96.
44. Rybak L.P., Ramkumar V. Ototoxicity. Kidney Int 2007, 72:931-935.
45. Liu H.Y., Chi F.L., Gao W.Y. Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea. Neuroreport 2008, 19:117-120.
46. Heinrich U.R., Selivanova O., Brieger J., Mann W.J. Endothelial nitric oxide synthase upregulation in the cochlea of the guinea pig after intratympanic gentamicin injection. Eur Arch Otorhinolaryngol 2006, 263:62-68.
47. Yoshikawa T., Naito Y., Kondo M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1999, 1:469-480.
48. Hyun S.K., Jung H.A., Chung H.Y., Choi J.S. In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids from Ginkgo biloba yellow leaves. Arch Pharm Res 2006, 29:1074-1079.
49. Kang J.W., Kim J.D., Song K., Kim S.H., Yoon J.H., Kim K.S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res 2010, 24 Suppl 1:577-582.
50. Chang T.K., Chen J., Teng X.W. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes. Drug Metab Dispos 2006, 34:234-242.
51. Rajaraman G., Chen J., Chang T.K. Ginkgolide A contributes to the potentiation of acetaminophen toxicity by Ginkgo biloba extract in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 2006, 217:225-233.
52. Shi C., Zhao L., Zhu B., Li Q., Yew D.T., Yao Z., et al. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact 2009, 181:115-123.